Загрузка...
Characterization of the Effect of Renal Impairment on Upadacitinib Pharmacokinetics
Upadacitinib is a novel selective Janus kinase 1 inhibitor developed for treatment of rheumatoid arthritis and other autoimmune diseases. The objective of this study was to assess the pharmacokinetics and safety of a single upadacitinib dose in subjects with normal renal function and in subjects wit...
Сохранить в:
| Опубликовано в: : | J Clin Pharmacol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6590375/ https://ncbi.nlm.nih.gov/pubmed/30633369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.1375 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|